HIGHLIGHTS
- who: Machteld M. Tiemessen and colleagues from the Bethesda, MD, USA have published the research: Protection against Marburg Virus and Sudan Virus in NHP by an Adenovector-Based Trivalent Vaccine Regimen Is Correlated to Humoral Immune Response Levels, in the Journal: Vaccines 2022, 10, 1263. of 29/06/2022
- what: To examine whether similar predictions may apply to the SUDV and MARV-specific challenges, data from five independent studies (two SUDV and three MARV studies as represented in this article and as previously published ) were analyzed for a correlation between GP-binding antibody concentrations and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.